Update shared on 17 Nov 2025
Fair value Increased 32%Analysts have raised their target price for Técnicas Reunidas from €22.54 to €29.67. They cite increased fair value estimates driven by improved profit margins and a lower discount rate, even though revenue growth forecasts have moderated.
What's in the News
- Técnicas Reunidas issued earnings guidance for 2025, expecting revenues above EUR 6.25 billion (Company Guidance)
- The company hosted an Analyst/Investor Day for stakeholders and investors (Company Event)
Valuation Changes
- Consensus Analyst Price Target has increased from €22.54 to €29.67, reflecting a substantial upward revision.
- Discount Rate has decreased from 10.01 percent to 8.66 percent. This indicates a more favorable risk assessment.
- Revenue Growth Forecast has moderated from 1.73 percent to 1.33 percent, showing lower anticipated expansion.
- Net Profit Margin projection has risen slightly from 3.52 percent to 3.83 percent. This suggests improved profitability expectations.
- Future P/E ratio has moved up marginally from 12.39x to 12.79x, reflecting higher valuation multiples going forward.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.